In recent decades, there has been a growing shift towards the use of markets and quasi-markets in healthcare provision and an increasing managerialism in the context of major increases in expenditure. The paper offers some comparative data on these trends and poses some basic questions as to whose interests have been served by this and whether this has been the best way to improve patient provision and health outcomes.
This issue of the IMJCP contains a group of articles dealing with the issue of public health and public wealth. In their different ways these articles address the question of the link between forms of economic and social organisation, types of health service provision and health outcomes. This is a controversial area and the papers offer both explicit and implicit criticism of some of the dominant ideas of the last two decades.
The expansion of 'managerialism' has involved a restructuring and colonisation of what were once seen as 'public services' and an attempt to turn 'professionals' into 'managers' and 'leaders' or to put in new managerial levels with alleged generic management skills above 'the professionals'. Nowhere has this been more evident than in healthcare. It is easy to see why this might be attractive to groups seeking commercial advantage. The share of resources going to health has risen in all countries and especially in the advanced world where the long run data is set out in Table 1. 'Health' is an attractive market for private healthcare providers, big pharma, management consultants and business schools offering courses in healthcare leadership etc. Governments too face budget pressures and can easily be swayed by the argument that markets, pseudo-private and private provision are more efficient than state provision or any third more co-operative form that might be imagined. Cynics will argue too that having a huge sector like healthcare (and related services like education) at least semi-detached from the market also undermines the wider legitimacy of market ideas for it suggests that we cannot trust private provision with things that are most precious to us. Source: OECD (2009) Pushing the market, commercialisation, privatisation, the use of pseudo market forms etc., has therefore been the order of the day and many theorists from healthcare economists to organisational change specialists have supported an agenda which includes, 'greater competition in service provision; disaggregation of units, hands on professional management …, private sector styles of management, tighter and more efficient use of resources, explicit standards and measures of performance, emphasis on output controls' (Dopson, 2007) . Table 2 uses the most recent OECD to show the share of public and private healthcare in a selection of OECD economies.
Once in place this increasing market orientation then finds an internal voice as new managerial layers in the health service providers have sought to legitimise their positions through the mutual endorsement of markets and managerialism. Academic supporters of change have assisted in this. As the process was getting under way in the early 1990s, for example, the health economist Alan Maynard wrote that 'unless we tackle the doctors, health reforms will fail to deliver … processes of healthcare are dominated by clinicians, who merely represent their own vested interests, [we must] strengthen the role of health managers and economists, who would speak for society at large' (Maynard, 1994) . Doctors may be a vested interest, as might nurses, catering staff and cleaners but the idea that 'health managers and economists' do not or have some special capacity to rise above their own vested interests and 'speak for society at large' stretched credulity in 1994 and it would seem to do so even more now.
These issues pose special problems in the USA and for readers there. Many of the arguments supporting markets and managerialism and their application to health have flowed from the USA to the world. Today, of course, the USA is riven with conflict over healthcare reform. Its system combines some of the best healthcare in the advanced world with some of the worst. It is always easier to see the faults in others but to outsiders the idea that, taken as a whole or in significant parts, the US healthcare system and its principles of operation should be a model will seem strange. Table 1 show that it is the most expensive healthcare system in the world. In these terms the USA is a complete outlier in any comparative international analysis of health. The various reasons why healthcare expenditure has grown so much in the USA have been explored elsewhere (see, for example, Bodenheimer, 2005) . But one component, as a leading US health economist makes clear, has been the additional layers that the US system involves.
"A major reason why it is so difficult to reduce costs is that every dollar of health care spending is a dollar of income to someone involved in providing health insurance or health care. Administrative costs are undoubtedly too high, and insurance companies taking excess profits and executives with high salaries are frequently blamed. But they are only a small part of the story. The biggest part consists of payments to tens of thousands of telephone and computer operators, claim payers, insurance salespersons, actuaries, benefit managers, consultants, and other low-and middle-income workers,. Overutilization of care is another problem that is not easily solved, partly because unnecessary or marginally useful tests, prescriptions, operations, and visits generate income for providers." (Fuchs, 2008) Moreover this is a system which fails to cover a significant part of the US population. The complexity of the system gives rise to measurement problems but Table 3 shows one attempt to measure long term trends in insurance coverage from which the uninsured proportion can be seen and the changing elements of the insured proportion as well as the issues that have helped to prompt the debate over healthcare reform.
This system, as Table 2 shows, depends more heavily on privatised medicine than in any other advanced economy but Table 2 also shows that health outcomes in the USA measured by life expectancy are not good in comparative terms. Life expectancy is, of course, a crude measure and is influenced by many factors but more sophisticated measures also tend to demonstrate that despite the enormous resources devoted to actual healthcare, and to administering that healthcare, the USA performs badly on international measures. Source: Cohen et al. (2009) The situation in the UK is no less controversial. Here too in the last decade there has been a major increase in health expenditure but this reflects in part the underfunding of the past. Whether the additional expenditure has all been used wisely is however another matter. Sadly tracing expenditure is difficult because the disaggregation of units precludes the easy collecting of some data. Table 4 , however, shows that, although administrative costs in the NHS remain relatively low in comparative terms, administrative and managerial layers here too have been growing as the more quasi market and market forms have been taken on. There is also controversy as to whether restructurings and new forms have had negative or positive health consequences. In 2010 scandal erupted with a report on one hospital trust which had been trying to achieve a greater degree of independence under the attempt to introduce more quasi-market choice, but which was revealed to have systematically distorted its processes to reach 'targets' at the cost of between 400 and 1200 patients lives (Francis, 2010) . The papers here in their different ways reflect the wider debate about the wisdom of this fascination of markets and management but one too little heard by mainstream management and business scholars -many of whom have been seduced, at least at the level of course provision, by the attractions of 'managerialist education'. The discussion here includes contributions from those researching in the business area but also those trained in medicine and epidemiology. We can frame these contributions by posing some basic questions.
1 Where should the analysis of health and healthcare start?
We can begin with a simple distinction, familiar in the medical world, but less so outside of it. This is the need to distinguish between upstream and downstream problems. The terms relate to a famous analogy usually attributed to the medical sociologist John McKinlay (McKinlay, 1979) . In this analogy healthcare is like a fast flowing river. You see a person passing by, struggling to keep their head above water. You jump in and save them and then notice another person coming down and another, each on the verge of drowning. Soon, your whole attention is devoted to dragging people out of the river to such an extent that you have no time to ask why, somewhere upstream, someone is pushing or something causing people to fall into the river.
The analogy has lost none of its force over the years. But in pointing to the need to focus on upstream issues -what causes problems in the first place -it poses the serious challenge to those who think about forms of economic and social organisation.
The starting point for any analysis of pubic health and public wealth must be why the pattern of diseases (morbidity) and death (mortality) is higher than it needs be and why it is so unequally distributed between different social groups. This is the case in all societies but it seems that the health gap is greatest in those societies where the level of economic inequality is the greatest. This is so whether we think in terms of physical ill health or mental ill health. Managers delude themselves if they think that they are under more stress than their office cleaners who survive on precarious work contracts, near or at minimum wage levels. Failure to address inequalities here means that healthcare will always be chasing after a socially determined level of ill health that could perhaps, with a different social and economic form of organisation, be reduced. Nobody has played a greater role in bringing these arguments to the fore that Professor Richard Wilkinson whose latest book, The Spirit Level with Professor Kate Pickett has attracted world wide attention (Wilkinson and Pickett, 2009 ). We are pleased therefore to offer readers a long interview with Wilkinson in which he sets out his ideas and elements of his own intellectual biography that fed into the arguments of Wilkinson and Pickett for increasing social and economic equality.
2 Is good health an input into the economic process or an independent goal to which the economy is an input?
Everybody today recognises the importance of health but they do so in different ways.
There is an economic case for 'good health' but there is also a health case for 'good economics'. They are not the same things. Economists and policymakers, and especially those close to neo-liberal and market theorising and policy-making, whether in national forums or international ones through the activities of the IMF and World Bank, see the health of the workforce as a positive input into better economic performance. Health, in other words, is not so much an end as a means -health and the healthcare system should be structured so as to achieve these positive economic outcomes. But what if health is the outcome and the economic system the input? Then it would seem that the economic system should be changed to achieve the best health outcomes. If Wilkinson and Pickett's arguments point in this direction so too does the second paper by Dr. Stephen Watkins who has been a leading figure in UK public health for many years. Watkins has not been afraid to take on economists on their own ground and returns here to an earlier challenge which has its roots in the arguments developed by Keynes in the midst of the earlier global economic crisis of that 1930s. Watkins asks readers to rethink some of the basic economic principles and challenges the medical profession not to be intimidated into separating out medical and economic arguments but to defend the idea of good health as an outcome and a measure by which we are judged.
3 Does the increasing marketisation help or hinder in the provision of good healthcare?
If we turn to downstream issues -to medical provision itself -the question that now arises is how much should be spent here and how should the expenditure be organised? Dr. Julian Tudor Hart has contributed to global health debates for some five decades at the same time as being, for many of them, a practising general practitioner pushing forward epidemiological research and research into the link between health and social conditions. His paper in this issue uses his long experience to challenge the marketisation of health and its outcomes. Hart too has distinguished himself not only by his grasp of clinical issues but his ability to mould a link between the economic and social analysis and healthcare. Here he argues that the attempt to treat patients as consumers not only introduces even more perverse incentives but compounds the lack of attention to the real role of patients as active co-producers in their own health and healthcare. This patient resource, which he suggests has never been properly utilised, can only really be fully engaged in a socialised system based around the idea of a gift economy whose logic can easily supported in both medical and economic terms.
4 How and to what extent can health providers play the role of 'good corporate citizens' in a more privatised and market system?
One way in which it is suggested today that the contradictions that emerge in each of the papers can be managed is if health service providers become 'good corporate citizens'. Our next paper is from Dr. John Middleton, another leading figure in public health in the UK who has combined writing and research with professional responsibilities. Here he draws on the debates that he has been involved in the past three decades as well as the experience of trying to use the concept of 'good corporate citizenship' to inform public health practice in a major urban centre characterised by considerable social deprivation.
The final paper returns to the debate stimulated by Wilkinson and Pickett over the nature of upstream problems. In The Spirit Level, Wilkinson and Pickett argue that one stand of reform that could contribute significantly to a more equal society and, therefore, less extreme health inequalities would be workplace reform to create less hierarchy and more democratic places of work. Here, Chris Yuil offers a sympathetic critique of this idea linking the familiar and sometimes less familiar discussion of the workplace in writing about business to the issue of the public health and public wealth discussed in the earlier papers in this issue.
